STOCK TITAN

[144] Cognex Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for Cognex Corp (CGNX) reports a proposed sale of 2,666 shares of Common Stock through broker Robert W Baird & Co., with an aggregate market value of $119,970 and approximate sale date of 09/05/2025 on NASDAQ. The filing shows the 2,666 shares were acquired through three Restricted Stock Unit releases on 02/21/2025, 02/22/2025 and 03/15/2025 totaling 2,666 shares, and fully settled upon vesting. The filing states there were no securities sold in the past three months by the reporting person. Filer contact and issuer identification fields in the notice are present but contain no specific names or CIK values in the provided content.

Avviso Form 144 per Cognex Corp (CGNX) segnala la proposta di vendita di 2.666 azioni di Common Stock tramite il broker Robert W Baird & Co., con un valore di mercato complessivo di $119.970 e data approssimativa di vendita 09/05/2025 su NASDAQ. La comunicazione indica che le 2.666 azioni sono state acquisite tramite tre rilasci di Restricted Stock Unit il 21/02/2025, 22/02/2025 e 15/03/2025, per un totale di 2.666 azioni, e sono state interamente regolate al momento del vesting. Nel modulo si dichiara che non sono stati venduti titoli nei tre mesi precedenti dalla persona che effettua la comunicazione. I campi di contatto del dichiarante e di identificazione dell'emittente sono presenti nella notifica ma non contengono nomi o valori CIK specifici nel contenuto fornito.

Aviso Formulario 144 para Cognex Corp (CGNX) informa de una propuesta de venta de 2.666 acciones de Common Stock a través del corredor Robert W Baird & Co., con un valor de mercado agregado de $119.970 y fecha aproximada de venta 09/05/2025 en NASDAQ. La presentación indica que las 2.666 acciones se adquirieron mediante tres liberaciones de Restricted Stock Units el 21/02/2025, 22/02/2025 y 15/03/2025, que suman 2.666 acciones, y que se liquidaron totalmente al vesting. El documento declara que no se vendieron valores en los últimos tres meses por parte de la persona que informa. Los campos de contacto del declarante y de identificación del emisor aparecen en el aviso pero no contienen nombres ni valores CIK específicos en el contenido proporcionado.

Cognex Corp (CGNX)에 대한 Form 144 통지는 중개인 Robert W Baird & Co.를 통해 보통주 2,666주를 매도할 예정임을 보고하며, 총 시가 총액 $119,970예상 매도일 09/05/2025로 NASDAQ에 등재되어 있습니다. 신고서에는 해당 2,666주가 2025-02-21, 2025-02-22, 2025-03-15에 이루어진 세 차례의 Restricted Stock Unit 해제에서 취득되어 총 2,666주이며 베스팅 시점에 전액 정산되었다고 명시되어 있습니다. 신고인은 지난 3개월 동안 판매한 증권이 없었다고 보고했습니다. 신고자 연락처 및 발행인 식별란은 통지서에 포함되어 있으나 제공된 내용에는 특정 이름이나 CIK 값이 기재되어 있지 않습니다.

Avis Form 144 pour Cognex Corp (CGNX) signale une proposition de vente de 2 666 actions ordinaires via le courtier Robert W Baird & Co., avec une valeur marchande totale de 119 970 $ et une date de vente approximative 09/05/2025 sur le NASDAQ. Le dépôt indique que les 2 666 actions ont été acquises par trois distributions de Restricted Stock Units les 21/02/2025, 22/02/2025 et 15/03/2025, pour un total de 2 666 actions, et ont été entièrement réglées à la levée des restrictions. Le document précise qu'aucun titre n'a été vendu au cours des trois derniers mois par la personne déclarante. Les champs de contact du déclarant et d'identification de l'émetteur figurent dans l'avis mais ne contiennent pas de noms ou de valeurs CIK spécifiques dans le contenu fourni.

Form 144-Mitteilung für Cognex Corp (CGNX) meldet einen geplanten Verkauf von 2.666 Aktien der Common Stock über den Broker Robert W Baird & Co., mit einem gesamten Marktwert von $119.970 und einem voraussichtlichen Verkaufstag 09/05/2025 an der NASDAQ. Die Einreichung gibt an, dass die 2.666 Aktien durch drei Freigaben von Restricted Stock Units am 21.02.2025, 22.02.2025 und 15.03.2025 erworben wurden, insgesamt 2.666 Aktien, und bei Vesting vollständig abgerechnet wurden. In der Meldung wird angegeben, dass die meldende Person in den letzten drei Monaten keine Wertpapiere verkauft hat. Die Felder für Kontakt des Meldenden und die Identifikation des Emittenten sind im Hinweis vorhanden, enthalten aber in den vorliegenden Angaben keine konkreten Namen oder CIK-Werte.

Positive
  • Disclosure of broker, share count, and market value provides clear, specific transaction details
  • Origin of shares documented as RSU releases with dates and settlement method
Negative
  • Filer and issuer identification fields are blank or not included in the provided content, limiting traceability
  • No name or CIK for the reporting individual is present in the supplied text

Insights

TL;DR: Small insider sale of vested RSUs proposed via a broker; immaterial to company market cap but discloses insider liquidity.

The filing documents a proposed sale of 2,666 shares valued at $119,970 scheduled for 09/05/2025 and transacted through Robert W Baird & Co. The shares originated from three RSU releases in February and March 2025, indicating disposition of recently vested equity compensation rather than open-market purchases. No prior sales in the last three months are reported. Given the companywide outstanding share count of 167,749,569 provided here, the sale represents a de minimis fraction of equity. The filing lacks explicit filer identity fields in the supplied content.

TL;DR: Disclosure aligns with Rule 144 mechanics; shows compliance but offers limited governance signal.

The notice follows Rule 144 disclosure conventions by identifying the broker, number of shares, acquisition dates, nature of acquisition (RSU releases), and intended sale date. The representation about absence of undisclosed material information is included as required. The document does not provide the reporting individuals name or CIK in the provided content, which limits assessment of the insiders role or pattern of sales. No material governance or compliance issues are evident from the disclosed items alone.

Avviso Form 144 per Cognex Corp (CGNX) segnala la proposta di vendita di 2.666 azioni di Common Stock tramite il broker Robert W Baird & Co., con un valore di mercato complessivo di $119.970 e data approssimativa di vendita 09/05/2025 su NASDAQ. La comunicazione indica che le 2.666 azioni sono state acquisite tramite tre rilasci di Restricted Stock Unit il 21/02/2025, 22/02/2025 e 15/03/2025, per un totale di 2.666 azioni, e sono state interamente regolate al momento del vesting. Nel modulo si dichiara che non sono stati venduti titoli nei tre mesi precedenti dalla persona che effettua la comunicazione. I campi di contatto del dichiarante e di identificazione dell'emittente sono presenti nella notifica ma non contengono nomi o valori CIK specifici nel contenuto fornito.

Aviso Formulario 144 para Cognex Corp (CGNX) informa de una propuesta de venta de 2.666 acciones de Common Stock a través del corredor Robert W Baird & Co., con un valor de mercado agregado de $119.970 y fecha aproximada de venta 09/05/2025 en NASDAQ. La presentación indica que las 2.666 acciones se adquirieron mediante tres liberaciones de Restricted Stock Units el 21/02/2025, 22/02/2025 y 15/03/2025, que suman 2.666 acciones, y que se liquidaron totalmente al vesting. El documento declara que no se vendieron valores en los últimos tres meses por parte de la persona que informa. Los campos de contacto del declarante y de identificación del emisor aparecen en el aviso pero no contienen nombres ni valores CIK específicos en el contenido proporcionado.

Cognex Corp (CGNX)에 대한 Form 144 통지는 중개인 Robert W Baird & Co.를 통해 보통주 2,666주를 매도할 예정임을 보고하며, 총 시가 총액 $119,970예상 매도일 09/05/2025로 NASDAQ에 등재되어 있습니다. 신고서에는 해당 2,666주가 2025-02-21, 2025-02-22, 2025-03-15에 이루어진 세 차례의 Restricted Stock Unit 해제에서 취득되어 총 2,666주이며 베스팅 시점에 전액 정산되었다고 명시되어 있습니다. 신고인은 지난 3개월 동안 판매한 증권이 없었다고 보고했습니다. 신고자 연락처 및 발행인 식별란은 통지서에 포함되어 있으나 제공된 내용에는 특정 이름이나 CIK 값이 기재되어 있지 않습니다.

Avis Form 144 pour Cognex Corp (CGNX) signale une proposition de vente de 2 666 actions ordinaires via le courtier Robert W Baird & Co., avec une valeur marchande totale de 119 970 $ et une date de vente approximative 09/05/2025 sur le NASDAQ. Le dépôt indique que les 2 666 actions ont été acquises par trois distributions de Restricted Stock Units les 21/02/2025, 22/02/2025 et 15/03/2025, pour un total de 2 666 actions, et ont été entièrement réglées à la levée des restrictions. Le document précise qu'aucun titre n'a été vendu au cours des trois derniers mois par la personne déclarante. Les champs de contact du déclarant et d'identification de l'émetteur figurent dans l'avis mais ne contiennent pas de noms ou de valeurs CIK spécifiques dans le contenu fourni.

Form 144-Mitteilung für Cognex Corp (CGNX) meldet einen geplanten Verkauf von 2.666 Aktien der Common Stock über den Broker Robert W Baird & Co., mit einem gesamten Marktwert von $119.970 und einem voraussichtlichen Verkaufstag 09/05/2025 an der NASDAQ. Die Einreichung gibt an, dass die 2.666 Aktien durch drei Freigaben von Restricted Stock Units am 21.02.2025, 22.02.2025 und 15.03.2025 erworben wurden, insgesamt 2.666 Aktien, und bei Vesting vollständig abgerechnet wurden. In der Meldung wird angegeben, dass die meldende Person in den letzten drei Monaten keine Wertpapiere verkauft hat. Die Felder für Kontakt des Meldenden und die Identifikation des Emittenten sind im Hinweis vorhanden, enthalten aber in den vorliegenden Angaben keine konkreten Namen oder CIK-Werte.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Cognex (CGNX) disclose?

The filing discloses a proposed sale of 2,666 Common Stock shares via Robert W Baird & Co. with an aggregate market value of $119,970, approx. sale date 09/05/2025 on NASDAQ.

How were the 2,666 shares acquired according to the filing?

The shares were acquired through RSU releases on 02/21/2025, 02/22/2025, and 03/15/2025 and settled as vested Restricted Stock Unit awards.

Does the filing show recent sales by the reporting person?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What exchange and broker are named in the Form 144?

The proposed sale is to be executed on NASDAQ through broker Robert W Baird & Co located at the address shown in the notice.

Is the filer identity available in the provided content?

No. The provided content lists filer and issuer fields but does not include a specific name or CIK for the reporting individual in the supplied text.
Cognex Corp

NASDAQ:CGNX

CGNX Rankings

CGNX Latest News

CGNX Latest SEC Filings

CGNX Stock Data

7.43B
167.42M
0.29%
100.5%
3.18%
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
Link
United States
NATICK